Clinical Trial Update: Ad26.ZEBOV Booster in Children Previously Vaccinated With Ad26.ZEBOV and MVA-BN-Filo (EBOVAC Booster Study) [Phase 2]

View source ↗

Summary

Phase 2 trial of Ad26.ZEBOV booster in children previously vaccinated shows completed status with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ebola Virus Disease

Drugs mentioned

• Ad26.ZEBOV
• MVA-BN-Filo

Snippet

Sponsor: London School of Hygiene and Tropical Medicine | Conditions: Ebola Virus Disease | Phase 2 | Status: COMPLETED | Results posted: 2023-12-13